Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - China
More »

  • BIO Convention in China
    Beijing CHINA www.bio.org
    11-11-2013
  • China Dispatch: Clinical and Biobanking Activities
    Alliance, weighs in from Beijing. GEN's China Dispatches are issued by Sharon F. Terry, ... We are visiting China to continue several collaborations in biomedical research that we ...
    10-15-2013
  • Antisense Drugs Finally Turning the Corner
    ... The company has preclinical and clinical studies and development activities currently running in Australia, Europe, the United States, and China." One of the main advantages of ...
    10-15-2013
  • Auxilium Licenses Stendra from Vivus for Up to $300M
    licensing pact for products containing avanafil outside of Japan, North Korea, South Korea, China, Taiwan, Singapore, Indonesia, Malaysia, Thailand, Vietnam, and the Philippines. ...
    10-11-2013
  • Active Biotech and Hutchison China MediTech Get Rewarded
    Both Active Biotech and Hutchison China MediTech earned milestone payments today for ... Both Active Biotech and Hutchison China MediTech earned milestone payments today for ...
    10-9-2013
  • Eddingpharm Secures Immutep's ImmuFact IMP321 for Growing Stable
    to develop and market ImmuFact® IMP321 in mainland China, Hong Kong, Macau, and Taiwan. ... of driving the development of IMP321 in China," said John Hawken, CEO. "Immutep is ...
    10-7-2013
  • Merck & Co. Axes 8,500 in R&D Restructuring
    for most of its pharmaceutical and vaccine revenues - the U.S., Brazil, Canada, China, France, Germany, Japan, Korea, Russia, and the U.K. But Merck added it will reduce its ...
    10-1-2013
  • Tips for Working Optimally with CMOs
    Concerns apply to upstream and downstream operations alike. "In addition, labor rates are rising in places like India and China. Foreign manufacturers are coming under the U.S. ...
    10-1-2013
  • Prepping for the Clinic
    ... out-licensed BL-8030 (a preclinical asset for hepatitis C) to CTTQ, the leading Chinese pharma company in the liver disease space, in a regional deal for China and Hong Kong." ...
    10-1-2013
  • Advertorial: United States Pharmacopeial Convention
    ... With its headquarters in Rockville, MD, USP also has sites and offices in Hyderabad, India; Shanghai, China; São Paulo, Brazil; and Basel, Switzerland. USP-NF provides ...
    10-1-2013
  • GSK Sells Thrombosis Brands to Aspen for $1.13B
    Aspen will acquire near-global rights to the anticoagulants Arixtra and Fraxiparine. The deal excludes China, India, and Pakistan. An undisclosed number of employees committed to ...
    9-30-2013
  • Federal Data Shows R&D Spending Slide
    ... number of jobs since 2008-before the industry had been reshaped by the recession, the growth of biotech in China and the rest of Asia, and a wave of mergers and acquisitions. ...
    9-25-2013
  • Amgen Plans R&D Center in China
    research in China, the biotech giant and school said today. Under a memorandum of understanding signed by both, Amgen will co-locate its China R&D center with ...
    9-25-2013
  • Ph.D.s Need Not Apply
    ... Yong Pan, Ph.D., postdoctoral scholar at the Gladstone Institutes, says institutions should address the twin gaps he found in the 12 years since emigrating from China-the gap ...
    9-25-2013
  • AbbVie, Galapagos Ink Up to $405M CF Collaboration
    activities, with Galapagos retaining exclusive rights in China and South Korea, and co-promotion rights in its home country of Belgium, as well as the Netherlands and Luxembourg. ...
    9-24-2013
  • More »

    Journal Articles

  • China's vision for renewable energy: The status of bioenergy...
    Elizabeth R. Nesbitt, Paul Thiers, Johnway Gao, Sharon Shoemaker, Manuel Garcia-Perez, Julie Carrier, Joy Doran-Peterson, John Morgan, Guangyi Wang, Pierre Christian Wensel, Shulin Chen
    Industrial Biotechnology
    experts at the August 2010 "China Bioenergy Workshop" and its related technical tours. ... of current and future bioenergy and bioproduct research and commercialization in China.
  • The China Study: The Most Comprehensive Study of Nutrition Ever...
    Daniel Redwood, C. Norman Shealy
    Journal of Alternative and Complementary Medicine, The
    The China Study: The Most Comprehensive Study of Nutrition Ever Conducted and the Startling Implications for Diet, Weight Loss and Long-Term Health. Two Reviews The China Study: ...
  • Anisakiasis in China: The First Clinical Case Report
    Yuanhua Qin, Yongfu Zhao, Yixin Ren, Lili Zheng, Xiaodong Dai, Yuguo Li, Weifeng Mao, Yu Cui
    Foodborne Pathogens and Disease
    Anisakiasis in China: The First Clinical Case Report Foodborne Pathogens and Disease ... Here we report the first case of human anisakiasis in China. The patient, male, 56 years ...
  • AIDS Orphanages in China: Reality and Challenges
    Qun Zhao, Xiaoming Li, Linda M. Kaljee, Xiaoyi Fang, Bonita Stanton, Liying Zhang
    AIDS Patient Care and STDs
    AIDS Orphanages in China: Reality and Challenges AIDS Patient Care and STDs Abstract With the increasing number of AIDS orphans in China, the government has been building AIDS ...

GEN Poll

More » Poll Results » Archive »

Balancing Family and Career for Women Ph.D.s

Which changes made to academic culture are most likely to encourage women researchers to stay?

Suggest a Poll